市场调查报告书
商品编码
1370224
临床试验用品市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球临床试验用品市场规模达到23亿美元。展望未来,IMARC集团预计到2028年该市场将达到36亿美元,2023-2028年复合年增长率(CAGR)为7.4%。
临床试验用品是指用于进行科学实验、调查和临床研究的各种工具和设备。输液帮浦、雾化器和注射器针头是最常用的临床试验用品。它们主要用于进行检测、预防和治疗各种疾病的医学试验,分析治疗方法的效率,以及诊断各种感染性和代谢性疾病。它们在呼吸、肿瘤、心血管和神经手术中也被广泛应用。
生物製药产业的显着成长是推动市场成长的关键因素之一。随着创新药物输送系统的发展,临床试验在治疗爱滋病毒和癌症等疾病方面获得了巨大的吸引力。此外,促进冷链物流和监控技术发展的技术进步也是关键的成长诱导因素。产品製造商专注于优化生产和包装流程,以最大限度地减少浪费并提高整体成本效率。此外,合约研究组织(CRO)的新兴趋势也对市场成长产生正面影响。 CRO 使製药、生物技术和医疗器材製造商能够以合约形式外包研究活动,从而提高各种试验用品的利用率。其他因素,包括政府和非政府组织(NGO)为开发先进药物和治疗方法而进行的广泛研究和开发(R&D),预计将为市场创造积极的前景。
The global clinical trial supplies market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research. Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies. They are primarily used for conducting medical trials for detecting, preventing and treating various ailments, analyzing the efficiency of a treatment method, and in the diagnosis of various infectious and metabolic disorders. They also find extensive applications during respiratory, oncological, cardiovascular and neurological procedures.
Significant growth in the biopharmaceutical industry is one of the key factors driving the growth of the market. Clinical trials are gaining immense traction for treating diseases, such as HIV and cancer, along with the development of innovative drug delivery systems. Furthermore, technological advancements facilitating the development of cold chain logistics and monitoring technologies, are also acting as crucial growth-inducing factors. Product manufacturers are focusing on optimizing the production and packaging processes that can minimize wastage and enhance the overall cost-efficiency. Moreover, the emerging trend of contract research organizations (CROs) is also impacting the market growth positively. CROs enable the pharmaceutical, biotechnological and medical instrument manufacturers to outsource research activities on a contractual basis, thereby increasing the utilization of various trial supplies. Other factors, including extensive research and development (R&D) undertaken by both the governmental and non-governmental organizations (NGOs) for the development of advanced drugs and treatment methods, are expected to create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial supplies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.
Product Manufacturing
Packaging, Labeling and Storage
Logistics and Distribution
Based on the services, the market has been segmented into product manufacturing; packaging, labeling and storage; and logistics and distribution.
Phase I
Phase II
Phase III
Others
On the basis of the phase, the market has been segregated into phase I, phase II, phase III and others. At present, phase III exhibits a clear dominance in the market.
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
The market has been analyzed on the basis of the therapeutic area into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. Amongst these, oncology holds the largest market share.
Medical Device Industry
Biopharmaceuticals Industry
Pharmaceuticals Industry
Others
Based on the end-use industry, the market has been divided into medical devices, biopharmaceuticals, pharmaceuticals and others. Pharmaceuticals account for the majority of the total market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
On the geographical front, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa. Currently, North America enjoys the leading position in the market.
The report has also analysed the competitive landscape of the market with some of the key players being Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.